康益美集团山东合成生物技术有限公司闪耀世界前沿科技大会

Group 1 - The Fourth World Frontier Technology Conference will be held in September in Beijing, highlighting the importance of international scientific and technological cooperation [4][6]. - Kangyimei Group's Shandong Synthetic Biology Technology Co., Ltd. has been recognized for its innovative achievements in the probiotic industry, winning the "Frontier Technology Innovation Benchmark Case" award [1][3]. - The company showcased two milestone patent technologies: a method for preparing probiotics based on synthetic biology and a system for screening synthetic biological probiotics [1][2]. Group 2 - The patented method for preparing probiotics utilizes innovative gene editing and regulation techniques to optimize metabolic pathways, enabling efficient synthesis of specific functional substances like L-isoleucine [1][2]. - The screening method leverages advanced artificial intelligence and big data technologies to accurately select probiotic gene combinations, significantly improving efficiency and accuracy compared to traditional methods [2][3]. - The successful application of these technologies provides Kangyimei with a competitive advantage and broad market prospects, leading to high consumer trust and rapid business growth for distributors [2][3]. Group 3 - Kangyimei Group has a strong R&D team with expertise in synthetic biology, microbiology, and bioinformatics, ensuring the company maintains a leading position in technology development [3]. - The company actively collaborates with renowned research institutions and universities to integrate cutting-edge technologies and innovative ideas [3]. - Future plans include further investment in R&D, enhancing technological innovation, and expanding market reach in the probiotic industry [3].